SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): April 7, 2004
| Strategic Diagnostics Inc. |
| (Exact Name of Registrant Specified in Charter) |
| Delaware | 000-68440 | 56-1581761 | ||
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
| 111 Pencader Drive | ||
| Newark, DE | 19702 | |
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: (302) 456-6789
ITEM 12. Results of Operations and Financial Condition.
On April 7, 2004, Strategic Diagnostics Inc. issued a press release announcing that its Microtox® system had been proposed by the US EPA for whole effluent toxicity applications. A copy of that press release is being furnished as Exhibit 99.1 to this report.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| STRATEGIC DIAGNOSTICS INC. | ||
| By: | /s/ Stanley J. Musial | |
| Stanley J. Musial | ||
| Chief Financial Officer | ||
Dated: April 7, 2004
